Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine-protein kinase Yes (YES1) is a non-receptor tyrosine kinase belonging to the Src family. It plays a critical role in various cellular processes including cell growth, survival, apoptosis, cell adhesion, and cytoskeletal dynamics. It is considered an oncogenic target in several cancers, including small cell lung cancer.
Tyrosine kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on YES Proto-oncogene Tyrosine-Protein Kinase (YES1).